HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The regulation of hepatitis C virus (HCV) internal ribosome-entry site-mediated translation by HCV replicons and nonstructural proteins.

Abstract
Hepatitis C virus (HCV), the global leading cause of chronic liver disease, has a positive-sense, ssRNA genome that encodes a large polyprotein. HCV polyprotein translation is initiated by an internal ribosome-entry site (IRES) located at the 5' end of the viral genome, in a cap-independent manner, but the regulatory mechanism of this process remains poorly understood. In this study, we characterized the effect of HCV nonstructural proteins on HCV IRES-directed translation in both HCV replicon cells and transiently transfected human liver cells expressing HCV nonstructural proteins. Using bicistronic reporter gene constructs carrying either HCV or other viral IRES sequences, we found that the HCV IRES-mediated translation was specifically upregulated in HCV replicon cells. This enhancement of HCV IRES-mediated translation by the replicon cells was inhibited by treatment with either type I interferon or ribavirin, drugs that perturb HCV genome replication, suggesting that the enhancement is probably due to HCV-encoded protein function(s). Reduced phosphorylation levels of both eIF2alpha and eIF4E were observed in the replicon cells, which is consistent with our previous findings and indicates that the NS5A nonstructural protein may be involved in the regulatory mechanism(s). Indeed, transient expression of NS5A or NS4B in human liver cells stimulated HCV IRES activity. Interestingly, mutation in the ISDR of NS5A perturbed this stimulation of HCV IRES activity. All these results suggest, for the first time, that HCV nonstructural proteins preferentially stimulate the viral cap-independent, IRES-mediated translation.
AuthorsYupeng He, Wei Yan, Carlos Coito, Yu Li, Michael Gale, Michael G Katze
JournalThe Journal of general virology (J Gen Virol) Vol. 84 Issue Pt 3 Pg. 535-543 (Mar 2003) ISSN: 0022-1317 [Print] England
PMID12604803 (Publication Type: Comparative Study, Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Antiviral Agents
  • Eukaryotic Initiation Factor-2
  • Eukaryotic Initiation Factor-4E
  • Interferon Type I
  • NS4 protein, hepatitis C virus
  • Polyproteins
  • Viral Nonstructural Proteins
  • Ribavirin
  • NS-5 protein, hepatitis C virus
Topics
  • Antiviral Agents (pharmacology)
  • Cell Line
  • Eukaryotic Initiation Factor-2 (metabolism)
  • Eukaryotic Initiation Factor-4E (metabolism)
  • Genome, Viral
  • Hepacivirus (genetics)
  • Humans
  • Interferon Type I (pharmacology)
  • Phosphorylation
  • Polyproteins (genetics)
  • Protein Biosynthesis (drug effects)
  • Replicon (physiology)
  • Ribavirin (pharmacology)
  • Transfection
  • Up-Regulation
  • Viral Nonstructural Proteins (genetics, physiology)
  • Virus Replication (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: